OpenVSafe by OpenVAERS
Search V-safe

LB8-11684-99084

3 vaccinations 3 coded responses 17 check-ins 2 free-text entries 5 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
665 / KS
Registered
2021-01-10
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-20
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-10
    Registered in v-safe
  3. 2021-01-10
    Dose 2 — Pfizer-BioNTech
  4. 2021-01-10
    Health check-in — day 0, dose 2
    Feeling: Good · Headache
    Adult check-in
  5. 2021-01-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  6. 2021-01-11
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  7. 2021-01-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  8. 2021-01-12
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  9. 2021-01-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work
    Adult check-in
  10. 2021-01-13
  11. 2021-01-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness, Nausea, Vomiting · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Adult check-in
  12. 2021-01-14
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  13. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Nausea
    Adult check-in
  14. 2021-01-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-01-19
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-01-24
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-02-02
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-02-08
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-02-14
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-02-23
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-05
  22. 2021-07-11
    Survey response — 6 months, dose 2
    MedDRA: Headache, Pyrexia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Fever increased to 102.5 with splitting headache
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2022-01-12
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  24. 2022-02-10
    Dose 3 — Moderna
  25. 2022-05-14
    Survey response — 3 months, dose 3
    MedDRA: COVID-19, Tonsillolith — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Feb 14 Covid positive Tonsil stones
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-05-14
    Report sent to call center — 3 months, dose 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  27. 2022-05-16
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  28. 2023-02-12
    Survey response — 12 months, dose 3
    MedDRA: COVID-19 — Feeling: Good · Be unable to do your normal daily activities
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12020-12-20Pfizer-BioNTech
22021-01-10Pfizer-BioNTech
32022-02-10Moderna No

Call center

5 call center cases

2 successful · 3 unsuccessful

See the call center timeline

Free text

Release 9 — 6 months, dose 2

2021-07-11

Symptoms: Fever increased to 102.5 with splitting headache

Release 11 — 3 months, dose 3

2022-05-14

Symptoms: Feb 14 Covid positive Tonsil stones

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDHeadache ✓ ✓ ✓
SDPyrexia ✓ ✓ ✓
SDTonsillolith · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release